Filing Flows › Attovia Therapeutics (ATTO) › Stock forecast & fair value
Attovia Therapeutics (ATTO) stock forecast and price target
Attovia Therapeutics (ATTO) trades at $15.27. 5 analysts' median price target is $45.00 (+195%), from $30.00 to $52.00.
Attovia Therapeutics' latest quarter
Attovia Therapeutics, Q2 2026: revenue $450K, net loss $20.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ATTO stock?
The median of 5 analysts' 12-month targets is $45.00, +195% from $15.27; the range is $30.00 to $52.00. The average rating is strong buy.
Does Attovia Therapeutics usually beat earnings estimates?
It beat the consensus EPS estimate in 0% of the quarters on record.
Is ATTO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.